Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP993250priorityCriticalpatent/ECSP993250A/en
Publication of ECSP993250ApublicationCriticalpatent/ECSP993250A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Plural Heterocyclic Compounds
(AREA)
Abstract
La invención se refiere a polimorfos de ácido 4¿[2-n-propil-4-metil-6-(1-metilbencimidazol-2-il)bencimidazol-1-ilmetil] bifenil-2-carboxilico (INN: telmisartán), en particular la forma B polimorfa, a mezclas de los polimorfos, a un procedimiento para la preparación de Telmisartán con contenido en la forma B, asi como a su empleo para la preparación de un medicamento.The invention relates to polymorphs of 4? [2-n-propyl-4-methyl-6- (1-methylbenzimidazol-2-yl) benzimidazol-1-ylmethyl] biphenyl-2-carboxylic acid (INN: telmisartan), in In particular, the polymorphic form B, mixtures of the polymorphs, a process for the preparation of Telmisartan containing form B, as well as its use for the preparation of a medicine.
ECSP9932501999-12-031999-12-03
POLYMORPHES OF TELMISARTAN, PROCEDURE FOR ITS PREPARATION AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
ECSP993250A
(en)
AMIDAS OF ANTRANILIC ACIDS WITH SIDE CHAIN OF HETEROARILSULFONILO, PROCEDURE FOR THEIR PREPARATION, ITS EMPLOYMENT AS A MEDICINAL OR DIAGNOSTIC AGENT, AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THEM
OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT.
GUANIDINE COMPOUNDS, ANTAGONISTS OF IL-8 RECEPTORS, A PHARMACEUTICAL COMPOSITION CONTAINING THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
A COMPOUND DERIVED FROM ARGININE, A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO ANALOGONIZE A RECEIVER FOR C3A